國家衛生研究院 NHRI:Item 3990099045/7231

NHRI > National Institute of Infectious Diseases and Vaccinology > Chia-Yu Chi > Periodical Articles > Item 3990099045/7231

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/7231

Title:	Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: A randomized controlled trial
Authors:	Chi, CY;Khanh, TH;Thoa, LP;Tseng, FC;Wang, SM;Thinh, LQ;Lin, CC;Wu, HC;Wang, JR;Hung, NT;Thuong, TC;Chang, CM;Su, IJ;Liu, CC
Contributors:	Division of Infectious Diseases
Abstract:	OBJECTIVE:: Enterovirus 71-induced brainstem encephalitis with pulmonary edema and/or neurogenic shock (stage 3B) is associated with rapid mortality in children. In a small pilot study, we found that milrinone reduced early mortality compared with historical controls. This prospective, randomized control trial was designed to provide more definitive evidence of the ability of milrinone to reduce the 1-week mortality of stage 3B enterovirus 71 infections. DESIGN:: Prospective, unicenter, open-label, randomized, controlled study. SETTING:: Inpatient ward of a large tertiary teaching hospital in Ho Chi Minh City, Vietnam. PATIENTS:: Children (</=18 yr old) admitted with proven enterovirus 71-induced pulmonary edema and/or neurogenic shock. INTERVENTIONS:: Patients were randomly assigned to receive intravenous milrinone (0.5 mug/kg/min) (n = 22) or conventional management (n = 19). Both groups received dopamine or dobutamine and intravenous immunoglobulin. MEASUREMENTS AND MAIN RESULTS:: The primary endpoint was 1-week mortality. The secondary endpoints included length of ventilator dependence and hospital stay and adverse events. The median age was 2 years with a predominance of boys in both groups. The 1-week mortality was significantly lower, 18.2% (4/22) in the milrinone compared with 57.9% (11/19) in the conventional management group (relative risk = 0.314 [95% CI, 0.12-0.83], p = 0.01). The median duration of ventilator-free days was longer in milrinone treatment group (p = 0.01). There was no apparent neurologic sequela in the survivors in either group, and no drug-related adverse events were documented. CONCLUSIONS:: Milrinone significantly reduced the 1-week mortality of enterovirus 71-induced pulmonary edema and/or neurogenic shock without adverse effects. Further studies are needed to determine whether milrinone might be useful to prevent progression of earlier stages of brainstem encephalitis.
Date:	2013-07
Relation:	Critical Care Medicine. 2013 Jul;41(7):1754-1760.
Link to:	http://dx.doi.org/10.1097/CCM.0b013e31828a2a85
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0090-3493&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000320579800039
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880572671
Appears in Collections:	[Chia-Yu Chi] Periodical Articles [Fan-Chen Tseng] Periodical Articles [Chung-Ming Chang] Periodical Articles [Ih-Jen Su(2002-2015)] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB23685637.pdf		467Kb	Adobe PDF	676	View/Open

Loading...